Skip to main content
HHS Logo U.S. Department of Health & Human Services Divider arrow NIH logo National Institutes of Health Alt desc
Strategic Alliances

Invention E-050-2012/0

Cyclodextrins as Therapeutics for Lysosomal Storage Disorders

Lead Inventor: Wei Zheng (NCATS)
Inventors: Juan Marugan (NCATS), John McKew (NCATS), Manju Swaroop (NHGRI), Miao Xu (NHGRI)
Ref. No.: E-050-2012/0

Abstract: Cyclodextrins, alone or in combination with other agents (e.g., vitamin E), as therapeutics for the treatment of lysosomal storage disorders caused by the accumulation of non-cholesterol lipids.


δ-Tocopherol Reduces Lipid Accumulation in Niemann-Pick Type C1 and Wolman Cholesterol Storage Disorders
Journal of Biological Chemistry • Nov. 16, 2012 • Therapeutics for Rare and Neglected Diseases

Evaluation of Cholesterol Reduction Activity of Methyl-β-Cyclodextrin Using Differentiated Human Neurons and AstrocytesJournal of Biomolecular Screening • October 2012 • Therapeutics for Rare and Neglected Diseases